Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Alfa-2a for Patients Who Have Received Cancer Vaccines
NCT02159482Phase 2Terminated
- Sponsor
- Duke University
- Start
- Nov 2005
- Primary completion
- May 2008
- Modality
- rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 2 trial of interferon alfa-2a in cancer, sponsored by Duke University. Started Nov 2005; status: terminated.
02
Drugs
interferon alfa-2a
03
Conditions
cancer
Beyond the preview
Go deeper on NCT02159482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02159482.